PHASE I/II TRIALS OF WR-2721 AND CISPLATINUM

被引：84

作者：

GLOVER, D

GLICK, JH

WEILER, C

FOX, K

TURRISI, A

KLIGERMAN, MM

机构：

[1] UNIV PENN,CTR CANC,DEPT RADIAT THERAPY,PHILADELPHIA,PA 19104

[2] UNIV PENN,CTR CANC,HEMATOL ONCOL SECT,PHILADELPHIA,PA 19104

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1986年 / 12卷 / 08期

关键词：

D O I：

10.1016/0360-3016(86)90205-1

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1509 / 1512

页数：4

共 20 条

[1] ALSARRAF M, 1982, CANCER TREAT REP, V66, P31
[2] Chabner B A, 1982, PHARM PRINCIPLES CAN
[3] EINHORN LH, 1980, CANCER, V46, P1339, DOI 10.1002/1097-0142(19800915)46:6<1339::AID-CNCR2820460607>3.0.CO
[4] 2-J
[5] GERSHENSON DM, 1981, OBSTET GYNECOL, V58, P487
[6] PHASE-I TRIALS OF WR-2721 AND CIS-PLATINUM
GLOVER, D
GLICK, JH
WEILER, C
YUHAS, J
KLIGERMAN, MM
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (09): : 1781 - 1784
[7] RADIOBIOLOGICAL AND BIOCHEMICAL STUDIES OF THIOPHOSPHATE RADIOPROTECTIVE COMPOUNDS RELATED TO CYSTEAMINE
HARRIS, JW
PHILLIPS, TL
[J]. RADIATION RESEARCH, 1971, 46 (02) : 362 - &
[8] CURRENT CONCEPTS - CHEMOTHERAPY IN HEAD AND NECK-CANCER
HONG, WK
BROMER, R
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (02) : 75 - 79
[9] KELSEN DP, 1982, CANCER, V49, P1174, DOI 10.1002/1097-0142(19820315)49:6<1174::AID-CNCR2820490618>3.0.CO
[10] 2-W